Evidence map›Paper›PMID 38460079›Full record

ArticleMolecular neurobiology2024

TXNIP Regulates NLRP3 Inflammasome-Induced Pyroptosis Related to Aging via cAMP/PKA and PI3K/Akt Signaling Pathways.

Xiaoshuang Xi, Rong Zhang, Yijia Chi, Ziman Zhu, Ruifeng Sun, Weijun Gong

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Loss of Peroxiredoxin 6 Drives Age-Related Klf9/NF-Antioxidants (Basel, Switzerland) · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Xiaoshuang Xi *Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Rong Zhang *The Second Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, Yunnan, China.
Yijia ChiBeijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Ziman ZhuBeijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Ruifeng SunBeijing Rehabilitation Hospital, Capital Medical University, Beijing, China.
Weijun GongDepartment of Neurological Rehabilitation, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China. gwj197104@ccmu.edu.cn.ORCID http://orcid.org/0000-0002-9134-8218
Capital Medical University · CNYunnan University · CN

Funding

Capital Funds for Health Improvement and Research 2022-1-2251National Natural Science Foundation of China 82372557Natural Science Foundation of Beijing Municipality 7222101
6 · The paper itself

Abstract

Aging is an inevitable natural process with time-dependent dysfunction and the occurrence of various diseases, which impose heavy burdens on individuals, families, and society. It has been reported that NLRP3 inflammasome-induced pyroptosis contributes significantly to age-related diseases and aging, while TXNIP is suggested to be involved in regulating pyroptosis mediated by NLRP3. However, the mechanism between TXNIP and NLRP3 inflammasome is still unclear. In this study, we used HT-22 cells to explore the effect of TXNIP on pyroptosis and its potential association with the aging. Also, we delved into the underlying mechanisms. Our findings revealed that TXNIP significantly augmented pyroptosis in HT-22 cells, primarily by enhancing the activation of the NLRP3 inflammasome and promoting the release of proinflammatory cytokines. Remarkably, as TXNIP levels increased, we observed a corresponding rise in the number of p16-positive cells, which is indicative of aging. Furthermore, we conducted experiments to modulate the improvement of TXNIP on NLRP3 inflammasome-induced pyroptosis, that is, the PI3K activator 740 Y-P and the PKA activator DC2797 inhibited the effect, while the PI3K inhibitor LY294002 and the PKA inhibitor H89 enhanced the effect. In conclusion, our study demonstrated that TXNIP regulates NLRP3 inflammasome-induced pyroptosis in HT-22 cells related to aging via the PI3K/Akt and cAMP/PKA pathways.

Indexed as

AgingCarrier ProteinsCyclic AMPCyclic AMP-Dependent Protein KinasesInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktPyroptosisSignal TransductionAnimalsCell LineMiceThioredoxinsCarrier ProteinsCyclic AMPCyclic AMP-Dependent Protein KinasesInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktThioredoxinsTxnip protein, mouseAgingcAMP/PKANLRP3PI3K/AktPyroptosisTXNIP

Identifiers

PMID38460079
OpenAlexW4392622473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.